Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: Critical appraisal

Clinical Microbiology and Infection

Volumn 19, Issue 12, 2013, Pages 1115-1121

  Leroux, S ^a   Ullmann, A J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aspergillus; Candida; Mucormycosis; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; EFUNGUMAB; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

DIAGNOSTIC TEST; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; MUCORMYCOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMIC MYCOSIS;

ASPERGILLUS; CANDIDA;

ASPERGILLUS; CANDIDA; MUCORMYCOSIS; TREATMENT;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS, INVASIVE; EVIDENCE-BASED MEDICINE; HUMANS; MUCORMYCOSIS; MYCOSES; PRACTICE GUIDELINES AS TOPIC; PYRIMIDINES; TRIAZOLES;

EID: 84888021773     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12426     Document Type: Review

References (22)

1. Ullmann AJ, Cornely OA, Donnelly JP et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 2012; 18: 1-8.
2. Cuenca-Estrella M, Verweij PE, Arendrup MC et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18: 9-18.
3. Cornely OA, Basseti M, Calandra T et al. ESCMID guideline for the diagnosis and management of Candida diseases: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18: 19-37.
4. Hope WW, Castagnola E, Groll AH et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 2012; 18: 38-52.
5. Ullmann AJ, Akova M, Herbrecht R et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 2012; 18: 53-67.
6. Lortholary O, Petrikkos G, Akova M et al. ESCMID guideline for the diagnosis and the management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect 2012; 18: 68-77.
7. Cornely OA, Arikan-Akdagli S, Dannaoui E et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis. Clin Microbiol Infect 2014; 20 (Supplement 2). In press.
8. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
9. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360.
10. Maertens J, Marchetti O, Herbrecht R et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplant 2011; 46: 709-718.
11. Marchetti O, Lamoth F, Mikulska M et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-854.
12. Skiada A, Lanternier F, Groll AH et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013; 98: 492-504.
13. Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia. Bone Marrow Transplant 2012; 47: 1030-1045.
14. GRADE WORKING GROUP. Gradeworkinggroup.org [homepage in the Internet]. [place unknown]: The GRADE working group; c2005-2013 [updated July 02 2013; last accessed July 15 2013]. Available at: http://www.gradeworkinggroup.org/.
15. Reboli AC, Rotstein C, Pappas PG et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356: 2472-2482.
16. Skiada A, Pagano L, Groll A et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17: 1859-1867.
17. Vehreschild JJ, Birtel A, Vehreschild MJ et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol 2013; 39: 310-324.
18. Nivoix Y, Launoy A, Lutun P et al. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. J Antimicrob Chemother 2012; 67: 2506-2513.
19. Patel M, Kunz DF, Trivedi VM, Jones MG, Moser SA, Baddley JW. Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines. Diagn Microbiol Infect Dis 2005; 52: 29-34.
20. Pagano L, Caira M, Offidani M et al. Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). J Antimicrob Chemother 2010; 65: 2013-2018.
21. Sa MB, Zaragoza R. Critical overview of clinical guidelines relating to invasive fungal infections. Int J Antimicrob Agents 2008; 32 (suppl 2): S155-S159.
22. Ananda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis 2012; 25: 107-115.